Issue 2/2013
Content (17 Articles)
Association and CpG SNP analysis of HTR4 polymorphisms with suicidal behavior in subjects with schizophrenia
Gina Polsinelli, Clement C. Zai, John Strauss, James L. Kennedy, Vincenzo De Luca
Long-term decrease in immediate early gene expression after electroconvulsive seizures
Julien Braga Calais, Samira S. Valvassori, Wilson R. Resende, Gustavo Feier, Maria Carolina Pedro Athié, Sidarta Ribeiro, Wagner Farid Gattaz, João Quevedo, Elida Benquique Ojopi
Ganglionic blockade alters behavioral and cerebral metabolic responses to corticotropin releasing factor in the rat
Ulderico Freo, Carlo Ori
Immunogenicity of botulinum toxins
Markus Naumann, Lee Ming Boo, Alan H. Ackerman, Conor J. Gallagher
Comparative evaluation of the potency and antigenicity of two distinct BoNT/A-derived formulations
M. Brown, G. Nicholson, M. C. Ardila, A. Satorius, R. S. Broide, K. Clarke, T. Hunt, J. Francis
AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies
Robert A. Hauser, Daniel Truong, Jean Hubble, Chandra Coleman, Jean-Luc Beffy, Stephen Chang, Philippe Picaut
Levodopa increases speed of alternating movements in Parkinson’s disease patients
Thomas Müller, Sören Peters, Ali Harati
Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson’s disease under duodopa® therapy
Sabine Skodda, Thomas Müller
Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy
Jan Rusz, Roman Čmejla, Hana Růžičková, Jiří Klempíř, Veronika Majerová, Jana Picmausová, Jan Roth, Evžen Růžička
Anticoagulants versus antiplatelet drugs for cervical artery dissection: case for anticoagulants
John W. Norris
Why antiplatelet treatment in spontaneous internal carotid dissection?
O. Bajenaru, C. Tiu, B. Dorobat, F. Antochi
Steroids in bacterial meningitis: yes
Felix Benninger, Israel Steiner
Controversies in neurology, Vienna, 2012: Steroids in bacterial meningitis: no
Bettina Pfausler, Erich Schmutzhard
Is there room for non-dopaminergic treatment in Parkinson disease?
Abraham Lieberman, Narayanan Krishnamurthi
Is there room for new non-dopaminergic treatments in Parkinson’s disease?
Manuela Pilleri, Konstantinos Koutsikos, Angelo Antonini
Meta-analysis of the transforming growth factor-β1 polymorphisms and susceptibility to Alzheimer’s disease
Wei-wei Chang, Liu Zhang, Yue-long Jin, Ying-shui Yao